Even though it is a freely circulating proteoglycan, no direct evidence of ESM-1 Endocan or endothelial cell specific molecule-1 (ESM-1): A potential novel This dermatan sulphate proteoglycan, which is expressed by the vascular endothelium, has been found freely circulating in the bloodstream of healthy subjects.
THE J B C © 2001 by The American Society for Biochemistry ... Endocan Is a Novel Chondroitin Sulfate/Dermatan Sulfate Proteoglycan That Promotes Hepatocyte Growth Factor/Scatter Factor Mitogenic Activity* Received for publication, August 30, 2001, and in revised form, October 3, 2001 The higher serum endocan levels may be a risk factor for ... In conclusion, elevated serum endocan may be an important risk factor for hypertension, coronary artery disease and coronary slow flow. Monitoring serum endocan may be a consequential step forward in predicting the occurrence and development of these diseases. However, additional prospective studies are still needed to validate this conclusion. Endocan: A New Molecule Playing a Role in the Development ...
Current studies on endothelial biomarkers are focusing on circulating endothelial Structurally endocan is a cystein-rich proteoglycan carrying a single chain of The literature analysis has also revealed endocan test as a promising novel
Serum endocan levels as a marker of disease activity in patients with Behçet disease. Endocan is a novel human endothelial cell–specific molecule. The central role of leukocytes and endothelial dysfunction in the development of Behçet disease (BD) led us to hypothesize that endocan might be a marker of this disease. Circulating Endocan Is a Novel Chondroitin Sulfate/Dermatan Sulfate ...
Little, however, is known about mouse endocan, until recently. Two novel reports, 1 from Circulation Research 1 describing the effects of the genetic deletion of endocan on angiogenesis and inflammation and the other from Oncotarget 2 describing specific biochemical and functional characters for mouse endocan lift the veil on how can mouse
19 Feb 2020 These data demonstrated that peptides of endocan containing residues 4–12 and 9–17 could Endocan: a novel circulating proteoglycan.
Chem. [Full text] Endocan and the respiratory system: a review ... Delehedde M, Devenyns L, Maurage CA, Vivès RR. Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan. Int J Cell Biol.
2013;2013:705027. 4. Béchard D, Gentina T, Delehedde M, et al.
2001;276 a lesson from a circulating dermatan sulfate proteoglycan. Endocan, a new endothelial marker in human sepsis ...
Endocan—A Novel Inflammatory Indicator in Newly Diagnosed Patients With Hypertension: A Pilot Study Delehedde, M. Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem. 2001;276 a lesson from a circulating dermatan sulfate proteoglycan. Endocan, a new endothelial marker in human sepsis ... Objectives: a) To evaluate in septic patients the blood levels of endocan, a circulating proteoglycan, which regulates leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interactions in vitro; b) to determine whether endocan could be used as a diagnostic and prognostic marker in sepsis in the intensive care unit; and c) to study kinetics of endocan secretion by Endocan in cancers: a lesson from a circulating dermatan ... Mar 28, 2013 · 3. Endocan: An Atypical Structure for an Atypical Proteoglycan.
Two novel reports, 1 from Circulation Research 1 describing the effects of the genetic deletion of endocan on angiogenesis and inflammation and the other from Oncotarget 2 describing specific biochemical and functional characters for mouse endocan lift the veil on how can mouse International Journal of Cancer Management | Endocan ... Endocan, also called endothelial cell-specific molecule-1 (ESM-1), is a kind of secreted dermatan sulfate proteoglycan that is related to the tumorigenesis and tumor progression (9, 10). Endocan is a newly diagnosed endothelial cell activation marker . Circulating endocan and preeclampsia: a meta-analysis ... Abstract.
2001, 276 (51):48341-9 J. Biol. Chem.